Mosunetuzumab

Lunsumio (mosunetuzumab) is a prescription monoclonal antibody made by Genentech, Inc., used to treat certain types of follicular lymphoma in adults who have relapsed or not responded to other treatments. It's administered as an intravenous injection, available in concentrate forms like 1 mg/mL or 30 mg/30 mL vials. This information was generated using AI and is provided for informational and research purposes only.